Related Experiment Videos
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is
Abstract:
Adult C57 B1 mice were injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using two dosage regimens. Following a 20 mg/kg/hour X 4 schedule, the number of dopamine D2 receptors labeled by 3H-spiperone was significantly increased at 2 days following the last injection of MPTP (124 +/- 8.0% of control values; p less than 0.025). Scatchard analysis revealed an increase in the number of 3H-spiperone binding sites. No significant difference between the control and MPTP treated animals could be detected in 3H-spiperone binding at 4 and 6 days following the short term MPTP treatment. Similarly, a regimen of 30 mg/kg/day X 10 MPTP caused a transient increase in 3H-spiperone binding to dopamine D2 receptors (1 day: 143 +/- 12%, p less than 0.01; 10 days: 101 +/- 3.7%, p greater than 0.05). These results suggest that MPTP does not produce permanent supersensitivity of dopamine D2 receptors in the mouse.
Insights
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposure caused a temporary increase in dopamine D2 receptors in mice. This suggests MPTP does not induce permanent changes in these receptors.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin used to model Parkinson's disease.
- Dopamine D2 receptors play a crucial role in motor control and are implicated in neurodegenerative disorders.
Purpose of the Study:
- To investigate the effect of MPTP on dopamine D2 receptor binding in adult mice.
- To determine if MPTP-induced changes in dopamine D2 receptors are transient or permanent.
Main Methods:
- Adult C57 B1 mice were administered MPTP using two different dosage regimens.
- Dopamine D2 receptor binding was quantified using 3H-spiperone radioligand.
- Scatchard analysis was employed to assess receptor binding characteristics.
Main Results:
- A short-term MPTP regimen (20 mg/kg/hour X 4) significantly increased dopamine D2 receptor binding 2 days post-treatment (124% of control).
- This increase in binding sites was transient, with no significant differences observed at 4 and 6 days.
- A longer MPTP regimen (30 mg/kg/day X 10) also induced a transient increase in binding 1 day post-treatment (143% of control), which returned to baseline by day 10.
Conclusions:
- MPTP administration leads to a temporary upregulation of dopamine D2 receptors in mice.
- These findings suggest that MPTP does not induce permanent supersensitivity of dopamine D2 receptors.